228 related articles for article (PubMed ID: 37845417)
21. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.
Adler M; Larocca L; Trovato FM; Marcinkowski H; Pasha Y; Taylor-Robinson SD
HPB (Oxford); 2016 Aug; 18(8):678-83. PubMed ID: 27485062
[TBL] [Abstract][Full Text] [Related]
22. Predictive Value of Liver Stiffness Measurement by Magnetic Resonance Elastography for Complications after Liver Resection: A Systematic Review and Meta-Analysis.
Liang J; Qiu B; Yin S; Chen Y; Zhang S
Digestion; 2022; 103(5):357-366. PubMed ID: 35780768
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of preoperative liver stiffness measurements in primary HBV-positive hepatocellular carcinoma.
Qi M; Chen Y; Zhang GQ; Meng YJ; Zhao FL; Wang J; Ma J
Future Oncol; 2017 Dec; 13(30):2799-2810. PubMed ID: 29189041
[TBL] [Abstract][Full Text] [Related]
24. Liver stiffness as a predictor of hepatocellular carcinoma behavior in patients with hepatitis C related liver cirrhosis.
Lashen SA; Elshafei MM; Hablass FH; Alsayed EA; Hassan AA
Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):22-28. PubMed ID: 31831335
[TBL] [Abstract][Full Text] [Related]
25. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease.
Lee DH; Lee JM; Chang W; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2018 Aug; 28(8):3513-3521. PubMed ID: 29488082
[TBL] [Abstract][Full Text] [Related]
28. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma.
Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N
Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578
[TBL] [Abstract][Full Text] [Related]
29. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study.
Nahon P; Kettaneh A; Lemoine M; Seror O; Barget N; Trinchet JC; Beaugrand M; Ganne-Carrié N
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):214-9. PubMed ID: 19212210
[TBL] [Abstract][Full Text] [Related]
30. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.
Alonso López S; Manzano ML; Gea F; Gutiérrez ML; Ahumada AM; Devesa MJ; Olveira A; Polo BA; Márquez L; Fernández I; Cobo JCR; Rayón L; Riado D; Izquierdo S; Usón C; Real Y; Rincón D; Fernández-Rodríguez CM; Bañares R
Hepatology; 2020 Dec; 72(6):1924-1934. PubMed ID: 33022803
[TBL] [Abstract][Full Text] [Related]
31. Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes.
Wong JS; Wong GL; Chan AW; Wong VW; Cheung YS; Chong CN; Wong J; Lee KF; Chan HL; Lai PB
Ann Surg; 2013 May; 257(5):922-8. PubMed ID: 23001077
[TBL] [Abstract][Full Text] [Related]
32. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.
Hayashi H; Kamada Y; Fujii H; Takahashi H; Oeda S; Iwaki M; Kawaguchi T; Tomita E; Yoneda M; Tokushige A; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
Ultrasound Med Biol; 2023 Jul; 49(7):1658-1664. PubMed ID: 37120329
[TBL] [Abstract][Full Text] [Related]
34. Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.
John BV; Dang Y; Kaplan DE; Jou JH; Taddei TH; Spector SA; Martin P; Bastaich DR; Chao HH; Dahman B
Clin Gastroenterol Hepatol; 2024 Apr; 22(4):778-788.e7. PubMed ID: 38061410
[TBL] [Abstract][Full Text] [Related]
35. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M
Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742
[TBL] [Abstract][Full Text] [Related]
36. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
Kim SU; Lee JH; Kim DY; Ahn SH; Jung KS; Choi EH; Park YN; Han KH; Chon CY; Park JY
PLoS One; 2012; 7(5):e36676. PubMed ID: 22574212
[TBL] [Abstract][Full Text] [Related]
37. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
[TBL] [Abstract][Full Text] [Related]
38. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
Lee MH; Chen YT; Huang YH; Lu SN; Yang TH; Huang JF; Yin SC; Yeh ML; Huang CF; Dai CY; Chuang WL; Yu ML; Yang HI; Chen HY; Chen CJ
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1275-1285.e2. PubMed ID: 38365094
[TBL] [Abstract][Full Text] [Related]
39. Non-invasive assessment of hepatic fibrosis: comparison of MR elastography to transient elastography and intravoxel incoherent motion diffusion-weighted MRI.
Fu F; Li X; Chen C; Bai Y; Liu Q; Shi D; Sang J; Wang K; Wang M
Abdom Radiol (NY); 2020 Jan; 45(1):73-82. PubMed ID: 31372777
[TBL] [Abstract][Full Text] [Related]
40. Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria.
Pennisi G; Enea M; Romero-Gomez M; Bugianesi E; Wai-Sun Wong V; Fracanzani AL; de Ledinghen V; George J; Berzigotti A; Viganò M; Sebastiani G; Cannella R; Delamarre A; Di Maria G; Lange NF; Tulone A; Di Marco V; Cammà C; Petta S
Hepatology; 2024 Apr; 79(4):912-925. PubMed ID: 37796137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
